Clinical Trials Logo

Shortness of Breath clinical trials

View clinical trials related to Shortness of Breath.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06201494 Recruiting - Asthma Clinical Trials

Prospective Multicentre Study on Symptoms in First-onset Bronchial Asthma in Children and Adolescents

Start date: January 1, 2023
Phase:
Study type: Observational

Bronchial asthma may present with symptoms other than the commonly reported complaints (cough, chest tightness, shortness of breath and wheezing). Less common symptoms include chronic or recurrent productive cough, inspiratory dyspnoea or recurrent pneumonia. Children presenting with these symptoms are often diagnosed with asthma bronchiale and benefit from antiasthmatic management.

NCT ID: NCT05992324 Recruiting - Shortness of Breath Clinical Trials

A Validation Study to Evaluate the Performance of Caption Health Lung Guidance and Interpretation

Start date: July 17, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the efficacy of Caption LungAI.

NCT ID: NCT05667727 Recruiting - Asthma in Children Clinical Trials

The Effect of Nebulized Epinephrine in Asthma Exacerbation in Pediatric Age Group With the Standard Treatment Compared to Standard Treatment Using Improvement PRAM Score as a Primary Outcome

Start date: October 15, 2023
Phase: Phase 4
Study type: Interventional

Our study aiming to look in improvement of Pediatric Respiratory Assessment Measure (PRAM) score as a primary outcome. The secondary outcomes involving the need for second step management, need for admission and possible side effects. It's double blinded randomized control study comparing Nebulized Epinephrine with standard treatment (salbutamol + Ipratropium) versus the standard treatment only in pediatric patient. A pilot study will be conducted before to detect the sample size required and data will be collected at deferent interval post treatment targeting intension to treat for analysis.

NCT ID: NCT04827563 Recruiting - Multiple Myeloma Clinical Trials

Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib

Start date: March 22, 2021
Phase:
Study type: Observational

This study will explore why some multiple myeloma patients who receive carfilzomib (an anti-cancer medication) experience shortness of breath while others do not. The purpose of this research is to gather information on the effectiveness of the EndoPAT device, which is FDA-approved to assess the health of a patient's blood vessels. These assessments will help doctors leading the study determine the reasons why patients may develop shortness of breath (dyspnea) when being treated with carfilzomib and ways to better prevent this shortness of breath.